LACTATED RINGERS

B. Braun Medical Inc. has initiated a Class I nationwide recall for 95,412 containers of Lactated Ringer's Injection USP due to particulate matter. This critical event, impacting a vital intravenous solution, poses significant supply chain risks for healthcare providers. Procurement directors must urgently identify alternative suppliers to mitigate disruption and ensure patient safety, given the severe health implications of this contamination.

B. Braun Medical Inc. has initiated a Class II recall for 7,800 bags of Lactated Ringer's Injection USP due to potential leakage compromising sterility. This nationwide recall, initiated on March 22, 2024, highlights critical quality control vulnerabilities. Procurement and supply chain leaders must assess current inventory and B. Braun's remediation efforts to mitigate supply disruptions and patient safety risks.